Peter Sguigna is a Neurology physician affiliated with The University of Texas Southwestern Medical Center. OpenAlex indexes 50 publications with 500 citations (h-index 8); ClinicalTrials.gov lists 2 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
5201 Harry Hines Blvd
Graduate Medical Education
Dallas, TX 752357708
Telephone
214-590-8058Provider last certified this registry record 13 Apr 2021.
Clinical trials
- Study of the Clinical and Radiological Impact of Ravulizumab in People With Neuromyelitis Optica Spectrum Disorder
Sponsor: University of Texas Southwestern Medical Center
- Study of Circadian Focused Light Therapy in Progressive Multiple Sclerosis
Sponsor: University of Texas Southwestern Medical Center
- 31P-MRS Imaging to Assess the Effects of CNM-Au8 on Impaired Neuronal Redox State in Multiple Sclerosis.
Sponsor: Clene Nanomedicine
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
6 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- EMD Serono, Inc.Program year20255 payments$10,849openpaymentsdata.cms.gov ↗
- Amgen Inc.Program year20259 payments
- Amgen Inc.Program year20241 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Comparison of Pediatric Demyelinating Diseases using Axonal and Myelin-Sensitive MRI
American Journal of Neuroradiology
2026 - Clinical and radiological outcomes of directed treatment transitions from Gilenya <sup>®</sup> to generic fingolimod
Multiple Sclerosis Journal
2026
Similar KOLs
Other experts from the same institution or the same specialty.
Robert Toto, MD
The University of Texas Southwestern Medical Center
Abhimanyu Garg, MD
The University of Texas Southwestern Medical Center
Jing Chen, MD
The University of Texas Southwestern Medical Center
Raksha Jain, MD
The University of Texas Southwestern Medical Center
Bruce Miller, MD
University of California, San Francisco (UCSF)
Brett Kissela, MD
Medical College of Wisconsin
Bradley Boeve, MD
Mayo Clinic
Richard Lipton, MD
Albert Einstein College of Medicine
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”